Patent ID: 7393531

Claim:
A method for treating a patient suffering from a breast or ovarian cancerous disease comprising: administering to said patient an isolated monoclonal antibody or antigen binding fragment thereof produced in accordance with a method for the production of anti-cancer antibodies which are useful in treating said breast or ovarian cancerous disease, said isolated monoclonal antibody or antigen binding fragment thereof characterized as being cytotoxic against cells of said cancerous tissue; wherein said isolated monoclonal antibody or antigen binding fragment thereof is placed in admixture with a pharmaceutically acceptable adjuvant and is administered in an amount effective to mediate treatment of said cancerous disease; said antibody being an isolated monoclonal antibody or antigen binding fragment thereof which binds to the same epitope which is bound by the isolated monoclonal antibody produced by a hybridoma deposited with the ATCC as PTA-5643.